India doesn't need 'Bechara' like Kumaraswamy: Jaitley

Agencies
July 16, 2018

New Delhi, July 16: Union Minister Arun Jaitley on Monday noted that India's leader cannot be a 'Bechara' (weak person).

Jaitley's comment came days after Karnataka Chief Minister HD Kumaraswamy broke down expressed his unhappiness at holding the Chief Minister's position in the Congress-Janata Dal (Secular) coalition government in the state.

"Listening to these statements of an Honourable Chief Minister, my memory took me back to the dialogues of the tragedy era of Hindi cinema. If this is the consequence of a two-party coalition, what is it that a disparate group of parties with no ideological similarity offer to India? India's Prime Minister and his Government have to overcome the challenges that India faces today. He cannot be seen like the Chief Minister of Karnataka as a tragedy king. If such a coalition is a cup of poison, why even dream of inflicting it on the nation? The leader of the world's fastest-growing economy cannot be a 'Bechara'," he wrote in a blog post.

Continuing his attack at the Karnataka government and the Opposition parties, Jaitley stated that developments in Karnataka were an obvious consequence of a non-ideological opportunistic alliance with no positive agenda, the basis of which, he said, was to 'Keep Modi Out'.

"Such non-ideological opportunistic coalitions always get trapped within their own contradictions. Their only object is survival and not service of the nation. Their longevity is a suspect. If the Prime Minister of such a coalition has to weep before the cameras with an only wish of how to exit from office, it will be a scenario worse than the policy paralysis of UPA II. The Congress firmly believes that only members of one family can rule India. If anybody else gets a chance, he should be pushed to the desperation of throwing his hands up and weeping publicly," he noted.

With regards to the formation of a third front ahead of the general elections in 2019, Jaitley opined that stable politics was far from the political track record of the "ideologically flexible political groups."

"A group of disparate political parties are promising to come together. Some of their leaders are temperamental; the others occasionally change ideological positions. With many of them, such as TMC, DMK, TDP, BSP and the JD(S), the BJP has had an opportunity to share power. Some amongst this disparate group have an extremely dubious track record of governance. Some leaders are maverick and others include those who are either convicted or charged with serious allegations of corruption. There are many whose political support base is confined to either a few districts or to a particular caste," Jaitley noted.

He continued, "To rule a large country like India through coalitions is possible but the nucleus of a coalition has to be stable. It must have a large size, an ideologically defined position and a vested interest in honest governance. A federal front is a failed idea. It was experimented under Shri Charan Singh, Shri Chandrasekhar and by the United Front Government from 1996-98. Such a front with its contradictions, sooner or later, loses its balance and equilibrium."

Jaitley also noted that if vote bank politics takes precedence over crucial matters of national interest, such as growing terrorism, rising crude oil prices and a possible trade war, such a government would be a liability.

"We need, for the next one decade and more, a high trajectory growth. To confront these challenges, India needs a strong and cohesive Government. More so, it means a decisive political leadership. It needs a Government which is able to resist unfair pressures of either allies or regions. It is the high growth rate, investment into rural India and the social sectors, credibility and strength of the Indian economy which will help us to be domestically strong to meet these challenges. A leadership unsure of itself meets the challenge of eliminating poverty and transforming the world's fastest growing economy into a developed nation?" he asked.

Addressing an event on Saturday, a teary-eyed Kumaraswamy claimed that he was swallowing the pain of a coalition government in Karnataka.

"People are standing with bouquets to wish me, as one of their brothers became Chief Minister and they all are happy, but I'm not. I know the pain of coalition government. I became Vishkanth (Lord Shiva) and swallowed pain of this government," he said.

Kumaraswamy further said he wanted to become the Chief Minister of Karnataka to solve the problems of the people and fulfill the unfinished agenda of his father and former prime minister, H D Deve Gowda.

Comments

Well Wisher
 - 
Tuesday, 17 Jul 2018

Dear Mr. Jaitley,
Kannadigas can tolerate this single bechara. no problem. But all Indians are no longer can tolerate bunch of becharas. They are just waiting for 2019

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
January 4,2020

New Delhi, Jan 4: In more troubles for the former Finance Minister and senior Congress leader P Chidambaram, the Enforcement Directorate (ED) on Friday questioned him for over six hours in its probe into the Air India aircraft deal case, first time since his release from Tihar jail almost a month ago.

A senior ED official told IANS, "We questioned Chidambaram for over six hours today in the ongoing probe into the Air India deal with Airbus."

According to financial probe agency officials, Air India had planned to buy over 111 aircraft from Airbus and Boeing during the erstwhile United Progressive Alliance (UPA) government in 2009. This is the first time the ED has questioned the senior Congress leader in the Air India deal case.

The questioning of Chidambaram came for the first time since his release from the Tihar jail where he spent 106 days in connection with the INX Media money laundering case. He was released from Tihar on December 4 last year after he was granted bail by the Supreme Court. The former finance minister is also being investigated by the ED in a separate money-laundering cases of Aircel-Maxis deal.

An ED official said the contract to buy 43 aircraft from Airbus was finalised by a panel of ministers headed by Chidambaram in 2009. According to the ED, when the proposal to buy 43 aircraft from Airbus was sent to the Cabinet Committee on Security (CCS), there was a condition that the aircraft manufacturer would have to build training facilities and MRO (Maintenance, Repair and Overhaul) centres at a cost of Rs 70,000 crore. But later, when the purchase order was placed, the clause was removed.

The name of another UPA minister, Praful Patel, had also come up in the alleged scam in a charge sheet filed by the ED against corporate lobbyist Deepak Talwar on March 30 last year. Talwar was arrested last year by the ED after he was deported from the UAE.

The ED is probing the Air India-Indian Airlines merger; purchase of 111 aircraft from Boeing and Airbus at Rs 70,000 crore; ceding profitable routes and schedules to private airlines, and opening of training institutes with foreign investment.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 15,2020

New Delhi, May 15: The World Bank on Friday approved $1 billion 'Accelerating India's COVID-19 Social Protection Response Program' to support the country's efforts for providing social assistance to the poor and vulnerable households, severely impacted by the pandemic.

This takes the total commitment from the World Bank towards emergency COVID-19 response in India to $2 billion.

A $1 billion support was announced last month to support India's health sector.

The response to the COVID-19 pandemic around the world has required governments around the world to introduce social distancing and lockdowns in unprecedented ways, said Junaid Ahmad, World Bank Country Director in India in a webinar interaction with the media.

These measures, intended to contain the spread of the virus have, however, impacted economies and jobs – especially in the informal sector. India with the world's largest lockdown has not been an exception to this trend, he said.

Of the $1 billion commitment, $550 million will be financed by a credit from the International Development Association (IDA) – the World Bank's concessionary lending arm and $200 million will be a loan from the International Bank for Reconstruction and Development (IBRD), with a final maturity of 18.5 years including a grace period of five years.

The remaining USD 250 million will be made available after June 30, 2020.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 3,2020

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of the Oxford University developed Covid-19 vaccine candidate in the country.

Government officials said that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after a thorough evaluation based on the recommendations of the Subject Expert Committee (SEC) on Covid-19.

"The firm has to submit safety data, evaluated by the Data Safety Monitoring Board (DSMB), to the CDSCO before proceeding to phase 3 clinical trials," a senior official said.

"As per the study design, each subject will be administered two doses four weeks apart (first dose on day one and second dose on day 29) following which the safety and immunogenicity will be assessed at predefined intervals," the official said.

As a rapid regulatory response, the expert panel at the Central Drugs Standard Control Organisation (CDSCO) on Friday, after a detailed deliberation and considering the data generated on the vaccine candidate in phase 1 and 2 of the Oxford University trial, had recommended granting permission for phase 2 and 3 clinical trials of the potential vaccine, 'Covishield', on healthy adults in India,  the officials said.

Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.

The officials said that the SII had submitted a revised proposal on Wednesday after the SEC on July 28, following deliberation over its application, had asked it to revise its protocol for the phase 2 and 3 clinical trials besides seeking some additional information.

The panel had also recommended that the clinical trial sites which have been proposed for the study be distributed across India.

According to the revised proposal by the SII, 1,600 people aged above 18 years will participate in the trials across 17 selected sites, including AIIMS-Delhi, B J Medical College in Pune, Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Post Graduate Institute of Medical Education and Research in Chandigarh, AIIMS-Jodhpur, Nehru Hospital in Gorakhpur, Andhra Medical College in Visakhapatnam and JSS Academy of Higher Education and Research in Mysore.

"According to the application, it would conduct an observer-blind, randomised controlled study to determine the safety and immunogenicity of 'Covishield' on healthy Indian adults," the official said.

The SII, which has partnered with AstraZeneca, for manufacturing the Oxford vaccine candidate for Covid-19 had submitted its first application to the DCGI on July 25 seeking permission for conducting the phase 2 and 3 trials of the potential vaccine. 

Initial results of the first two-phases of trials of the vaccine conducted in five trial sites in the UK showed that it has an acceptable safety profile and homologous boosting increased antibody response, sources had said.

To introduce the vaccine, SII, the world's largest vaccine maker by number of doses produced and sold, has signed an agreement to manufacture the potential vaccine developed by the Jenner Institute (Oxford University) in collaboration with British-Swedish pharma company AstraZeneca. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.